COLORADO SPRINGS, Colo.–(EMWNews)–Spectranetics Corporation (Nasdaq:SPNC) today announced that it

will present at Canaccord Adams’ 28^th

Annual Global Growth Conference to be held in Boston from August 12-14

at the Intercontinental Boston Hotel.

John G. Schulte, Spectranetics’ president and

chief executive officer, is scheduled to speak on Wednesday, August 13,

2008 at 8:30 a.m. Eastern time (6:30 a.m. Mountain time) and will

discuss the Company’s strategic initiatives, product pipeline and market

opportunities.

Interested parties can access a live audio webcast and slide

presentation at www.spectranetics.com.

An archived presentation will be available on the Web site for 14 days.

The Canaccord Adams Global Growth Conference is one of the oldest and

largest programs showcasing both publicly traded and privately held

growth companies. Many of the presenting public companies are covered by

Canaccord Adams’ global team of equity

analysts. To learn more about the conference, please contact Nadine

Miller at 617.371.3842 or [email protected].

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer

laser approved in the United States, Europe and Japan for use in

minimally invasive cardiovascular procedures. This technology treats

complex cardiovascular conditions by photo-ablating multiple lesion

types into tiny particles that are easily absorbed into the blood

stream. The Company’s disposable catheters use

high-energy “cool”

ultraviolet light to vaporize arterial blockages in the legs and heart,

as well as scar tissue encapsulating pacing and defibrillation leads.

For more information visit www.spectranetics.com.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions